TOP
Chemotherapy at home
Download this case study

Summary

The delivery of chemotherapy treatment at home for people with cancer in Cheshire and Merseyside is estimated to have saved the NHS nearly £400,000 – with almost all patients saying they preferred receiving their treatment at home.

A trial of chemotherapy treatment at home was delivered by The Clatterbridge Cancer Centre NHS Foundation Trust with the support of the Innovation Agency, the Academic Health Science Network for the North West Coast, who funded a nursing post for delivery of the treatment during the trial.

The Clatterbridge Cancer Centre now provides chemotherapy treatment at home for nearly five per cent of all treatments, delivered by a team of five nurses and three administrators. Within the next three years the trust plans to expand the service to 10 per cent of all treatments.

The challenge

The Clatterbridge Cancer Centre provides oncology services in Merseyside, Cheshire and the Isle of Man, serving a population of 2.3 million over seven district hospitals. It is one of the largest cancer centres in the UK, registering nearly 10,000 patients every year.

Attending hospital for chemotherapy treatment can often be challenging for patients. Many rely on public transport, which for some patients can be costly and involve long journeys. Some patients are carers themselves, and have to make special arrangements so that they can leave home for their treatment. For some patients with severe learning difficulties it can be stressful to be outside the home environment.

Actions taken

In 2015 the Innovation Agency funded a nursing post service with The Clatterbridge Cancer Centre.

After evaluating the success of the trial The Clatterbridge Cancer Centre expanded the service to nearly five per cent of all treatments with a team of five nurses and three administrators. 

The Innovation Agency commissioned the Royal College of Physicians to undertake an economic analysis of the service over the course of 2017, during which 298 patients received 2,106 treatment episodes at home.

In 2018 The Clatterbridge Cancer Centre started delivering chemotherapy treatment in the workplace, the first trust in the UK to do so. The service has so far been delivered across 10 workplaces in Cheshire, Merseyside and Lancashire – including warehouses, offices, shops and cafes.

Impacts & Benefits

Research by the Royal College of Physicians estimated savings to the trust of £182 per treatment episode at home compared to in the hospital, resulting in total estimated savings of nearly £400,000. The research did not take into account NHS patient transport costs or missed appointments, meaning that total savings to the NHS are almost certainly higher.

Almost all home treatment patients who responded to a survey said they preferred treatment at home, and all respondents said they preferred treatment outside the hospital.

Testimonials

Helen Poulter-Clark, Chief Pharmacist at The Clatterbridge Cancer Centre NHS Foundation Trust, said: “Chemotherapy in the community has been one of our big success stories, not only for patients but for staff  as well. The fact that we’ve been able to do this using Clatterbridge nurses and Clatterbridge pharmacists rather than a home care company is fantastic.

“It’s part of a wider strategy – the more patients we treat at home, the more clinic capacity we have. We’ve also been the first cancer centre in the country to offer treatment at patients’ workplaces, and I’m really proud of that. Our patient satisfaction has been fantastic, and that’s the main reason we’re doing this.

“We talk about putting people first, and this has been fantastic for our staff as well. We’ve done this utilising our chemo nurses, and it’s a great diversification of their skills.”

Dorothy Probert, Manager of Clatterbridge in The Community, said: “The aim of chemotherapy at home is to reduce the travelling time for patients. For nurses it’s an opportunity to work in a different environment. I think as a nurse job satisfaction is really important. Being able to see patients have their treatment in a place where they prefer to have it, either their home or workplace, is really satisfying.”

Rosemary Jones, who has received chemotherapy treatment at home, said: “Parking was always a problem, and the ward I attended could be very busy. I would have to attend for treatment every third and fourth week, and have to go and have blood taken the day before my fourth week appointment.

“Treatment at home is so much better. I know in advance when to expect the nurse. They also take bloods the same day as the treatment, and ring me with the results. I can very easily fit treatments around my daily routine as I’m informed by the Home Treatment Office a week in advance whether my appointment will be in the morning or the afternoon.”
 

Transfer of care from hospitals to community pharmacies Read more

Pharmacies in Cheshire and Merseyside are being notified by their local hospital when a patient is discharged who might need help with their medication. The initiative, called Transfer of Care Around Medicines, is improving patient safety and quality of care – and saved the NHS in Cheshire and Merseyside an estimated £9.5 million over the three years to Spring 2019.

Digital appointment management in East Lancashire Read more

Switching from a traditional, letter-based appointment management system to a digital patient portal is saving one NHS trust in Lancashire over £120,000 a year – and freeing up 30,000 reusable appointments that would otherwise have been wasted.

Smartphone tech transforms home care in Liverpool Read more

Liverpool is leading the way in the use of smartphone technology to deliver and monitor care in people’s homes. The city is the first to introduce a digital system with almost all domiciliary care providers – giving instant information about 9,000 vulnerable residents to their families and professionals.

All the latest from the Innovation Agency...